Oracle Corporation (NYSE:ORCL) Shares Sold by Mezzasalma Advisors LLC

Mezzasalma Advisors LLC lowered its stake in shares of Oracle Corporation (NYSE:ORCL) by 3.8% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,478 shares of the enterprise software provider’s stock after selling 136 shares during the period. Mezzasalma Advisors LLC’s holdings in Oracle were worth $486,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Capital & Planning LLC grew its stake in Oracle by 0.5% during the fourth quarter. Capital & Planning LLC now owns 15,727 shares of the enterprise software provider’s stock worth $2,621,000 after buying an additional 81 shares during the period. Brighton Jones LLC lifted its holdings in shares of Oracle by 189.3% during the 4th quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock valued at $25,593,000 after acquiring an additional 100,494 shares in the last quarter. Union Bancaire Privee UBP SA purchased a new stake in Oracle during the 4th quarter worth $51,084,000. Revolve Wealth Partners LLC boosted its position in Oracle by 8.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock worth $903,000 after purchasing an additional 404 shares during the period. Finally, Valmark Advisers Inc. increased its holdings in Oracle by 6.5% in the 4th quarter. Valmark Advisers Inc. now owns 5,584 shares of the enterprise software provider’s stock valued at $930,000 after purchasing an additional 343 shares in the last quarter. Institutional investors and hedge funds own 42.44% of the company’s stock.

Oracle Trading Down 1.5%

NYSE:ORCL opened at $207.85 on Wednesday. The company has a market capitalization of $581.34 billion, a P/E ratio of 47.89, a P/E/G ratio of 3.13 and a beta of 1.32. The stock’s 50 day moving average price is $155.97 and its 200 day moving average price is $160.82. The company has a debt-to-equity ratio of 4.07, a quick ratio of 1.02 and a current ratio of 0.75. Oracle Corporation has a 52 week low of $118.86 and a 52 week high of $216.60.

Oracle (NYSE:ORCL) last posted its earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, topping the consensus estimate of $1.64 by $0.06. The company had revenue of $15.90 billion during the quarter, compared to the consensus estimate of $15.58 billion. Oracle had a net margin of 21.68% and a return on equity of 87.34%. The company’s revenue for the quarter was up 11.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.63 earnings per share. On average, research analysts forecast that Oracle Corporation will post 5 EPS for the current fiscal year.

Oracle Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 24th. Stockholders of record on Thursday, July 10th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, July 10th. This represents a $2.00 annualized dividend and a dividend yield of 0.96%. Oracle’s dividend payout ratio (DPR) is presently 46.08%.

Analysts Set New Price Targets

ORCL has been the subject of several analyst reports. Westpark Capital upped their target price on Oracle from $195.00 to $246.00 and gave the stock a “buy” rating in a research report on Thursday, June 12th. BMO Capital Markets raised Oracle from a “market perform” rating to an “outperform” rating and boosted their price target for the stock from $200.00 to $235.00 in a research report on Friday, June 13th. Cowen restated a “buy” rating on shares of Oracle in a report on Thursday, June 12th. JPMorgan Chase & Co. increased their price objective on shares of Oracle from $135.00 to $185.00 and gave the company a “neutral” rating in a research report on Thursday, June 12th. Finally, Cantor Fitzgerald dropped their price objective on shares of Oracle from $214.00 to $175.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 11th. Eleven investment analysts have rated the stock with a hold rating, twenty-one have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $194.32.

Insider Activity

In related news, Director Leon E. Panetta sold 5,000 shares of the company’s stock in a transaction on Friday, April 11th. The shares were sold at an average price of $129.77, for a total transaction of $648,850.00. Following the completion of the sale, the director now directly owns 58,090 shares of the company’s stock, valued at approximately $7,538,339.30. This represents a 7.93% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Vice Chairman Jeffrey Henley sold 400,000 shares of the firm’s stock in a transaction on Thursday, June 12th. The shares were sold at an average price of $190.42, for a total transaction of $76,168,000.00. Following the completion of the transaction, the insider now owns 1,097,576 shares in the company, valued at $209,000,421.92. The trade was a 26.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 427,366 shares of company stock valued at $80,183,723. Insiders own 42.20% of the company’s stock.

Oracle Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.